Akyildiz et al. (56) investigated the effect of MIF-173 G/C gene polymorphism in NAFLD and found no difference in genotype or C-allele frequency between healthy controls (n = 104) and NAFLD patients (n = 91). The gene discussed is MIF; the disease is metabolic dysfunction-associated steatotic liver disease.